These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 14593189)
41. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Schnall MD; Blume J; Bluemke DA; DeAngelis GA; DeBruhl N; Harms S; Heywang-Köbrunner SH; Hylton N; Kuhl CK; Pisano ED; Causer P; Schnitt SJ; Thickman D; Stelling CB; Weatherall PT; Lehman C; Gatsonis CA Radiology; 2006 Jan; 238(1):42-53. PubMed ID: 16373758 [TBL] [Abstract][Full Text] [Related]
42. Ductal enhancement on MR imaging of the breast. Liberman L; Morris EA; Dershaw DD; Abramson AF; Tan LK AJR Am J Roentgenol; 2003 Aug; 181(2):519-25. PubMed ID: 12876038 [TBL] [Abstract][Full Text] [Related]
43. Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy. Li SP; Makris A; Beresford MJ; Taylor NJ; Ah-See ML; Stirling JJ; d'Arcy JA; Collins DJ; Kozarski R; Padhani AR Radiology; 2011 Jul; 260(1):68-78. PubMed ID: 21502383 [TBL] [Abstract][Full Text] [Related]
44. MR imaging-guided 9-gauge vacuum-assisted core-needle breast biopsy: initial experience. Orel SG; Rosen M; Mies C; Schnall MD Radiology; 2006 Jan; 238(1):54-61. PubMed ID: 16304093 [TBL] [Abstract][Full Text] [Related]
45. Laser therapy for breast cancer: MR imaging and histopathologic correlation. Mumtaz H; Hall-Craggs MA; Wotherspoon A; Paley M; Buonaccorsi G; Amin Z; Wilkinson I; Kissin MW; Davidson TI; Taylor I; Bown SG Radiology; 1996 Sep; 200(3):651-8. PubMed ID: 8756910 [TBL] [Abstract][Full Text] [Related]
46. Assessment of suspected breast cancer by MRI: a prospective clinical trial using a combined kinetic and morphologic analysis. Wiener JI; Schilling KJ; Adami C; Obuchowski NA AJR Am J Roentgenol; 2005 Mar; 184(3):878-86. PubMed ID: 15728612 [TBL] [Abstract][Full Text] [Related]
47. Magnetic resonance imaging characteristics of paraffinomas and siliconomas after mammoplasty. Wang J; Shih TT; Li YW; Chang KJ; Huang HY J Formos Med Assoc; 2002 Feb; 101(2):117-23. PubMed ID: 12099202 [TBL] [Abstract][Full Text] [Related]
48. MR imaging assessment of the breast after breast conservation therapy: distinguishing benign from malignant lesions. Drukteinis JS; Gombos EC; Raza S; Chikarmane SA; Swami A; Birdwell RL Radiographics; 2012; 32(1):219-34. PubMed ID: 22236903 [TBL] [Abstract][Full Text] [Related]
49. Breast reduction in the irradiated breast: evidence for the role of breast reduction at the time of lumpectomy. Parrett BM; Schook C; Morris D Breast J; 2010; 16(5):498-502. PubMed ID: 21054644 [TBL] [Abstract][Full Text] [Related]
50. Assessment of local recurrence after breast-conserving therapy with MRI. Muüller RD; Barkhausen J; Sauerwein W; Langer R J Comput Assist Tomogr; 1998; 22(3):408-12. PubMed ID: 9606381 [TBL] [Abstract][Full Text] [Related]
51. Impact of radiotherapy on background parenchymal enhancement in breast magnetic resonance imaging. Kim YJ; Kim SH; Choi BG; Kang BJ; Kim HS; Cha ES; Song BJ Asian Pac J Cancer Prev; 2014; 15(7):2939-43. PubMed ID: 24815428 [TBL] [Abstract][Full Text] [Related]
52. Background parenchymal enhancement on breast MRI: influence of menstrual cycle and breast composition. Kang SS; Ko EY; Han BK; Shin JH; Hahn SY; Ko ES J Magn Reson Imaging; 2014 Mar; 39(3):526-34. PubMed ID: 23633296 [TBL] [Abstract][Full Text] [Related]